Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « index »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
independently < index < indexes  Facettes :

List of bibliographic references indexed by index

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000504 (2020) Ata Baytaro Lu [Turquie] ; Sibel Kadayifçilar [Turquie] ; Abdullah A In [Turquie] ; Özge Del Kta [Turquie] ; Selcan Dem R [Turquie] ; Yelda B Lg Ner [Turquie] ; Jale Karakaya [Turquie] ; Seza Özen [Turquie] ; Bora Eldem [Turquie]Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency
000762 (2019) Isidoro González-Álvaro [Espagne] ; Isabel Castrej N [États-Unis] ; Loreto Carmona [Espagne]The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity
000872 (2019) Niels W. Boone [Pays-Bas] ; Alexandre Sepriano [Pays-Bas, Portugal] ; Paul-Hugo Van Der Kuy [Pays-Bas] ; Rob Janknegt [Pays-Bas] ; Ralph Peeters [Pays-Bas] ; Robert B M. Landewé [Pays-Bas]Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice
000F22 (2019) Iain B. Mcinnes [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Maria-Antonietta D'Agostino [France] ; Manuela Le Bars [France] ; Subhashis Banerjee [États-Unis] ; Harris A. Ahmad [États-Unis] ; Yedid Elbez [France] ; Philip J. Mease [États-Unis]Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
000F23 (2019) Xia Feng [République populaire de Chine] ; Xizhu Xu [République populaire de Chine] ; Yanjun Shi [République populaire de Chine] ; Xuezhen Liu [République populaire de Chine] ; Huamin Liu [République populaire de Chine] ; Haifeng Hou [République populaire de Chine] ; Long Ji [République populaire de Chine] ; Yuejin Li [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Youxin Wang [République populaire de Chine] ; Dong Li [République populaire de Chine]Body Mass Index and the Risk of Rheumatoid Arthritis: An Updated Dose-Response Meta-Analysis
000F24 (2019) Hua Huang [République populaire de Chine] ; Han Cen [République populaire de Chine] ; Li Zhou [République populaire de Chine] ; Ting-Hui Wang [République populaire de Chine] ; Wen Qin [République populaire de Chine] ; Bin-Hua Xie [République populaire de Chine] ; Dong-Mei Xiao [République populaire de Chine] ; Xiu-Di Wu [République populaire de Chine] ; Hua-Xiang Wu [République populaire de Chine]Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
000F49 (2019) Uri Arad [Israël] ; Ori Elkayam [Israël]Association of Serum Tocilizumab Trough Concentrations with Clinical Disease Activity Index Scores in Adult Patients with Rheumatoid Arthritis.
001106 (2018) Alvise Berti [États-Unis] ; Divi Cornec [France] ; Jose R. Medina Inojosa [États-Unis] ; Eric L. Matteson [États-Unis] ; M Hassan Murad [États-Unis]Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index.
001684 (2017) Muznay N. Khawaja [États-Unis] ; Martin J. Bergman [États-Unis] ; Jeffrey Yourish [États-Unis] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Edward Keystone [Canada]Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
001879 (2017) Maria-Antonietta D Gostino [France] ; Rieke Alten [Allemagne] ; Eduardo Mysler [Argentine] ; Manuela Le Bars [France] ; June Ye [États-Unis] ; Bindu Murthy [États-Unis] ; Julia Heitzmann [France] ; Radu Vadanici [France] ; Gianfranco Ferraccioli [Italie]Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis
001B06 (2016) Seong-Kyu Kim [Corée du Sud] ; Jung-Yoon Choe [Corée du Sud] ; Sung-Hoon Park [Corée du Sud] ; Hwajeong Lee [Corée du Sud]No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
001C47 (2016) A. Gardette [France] ; S. Ottaviani [France] ; J. Sellam [France] ; F. Berenbaum [France] ; F. Lioté [France] ; A. Meyer [France] ; J. Sibilia [France] ; B. Fautrel [France] ; E. Palazzo [France] ; P. Dieudé [France]Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
001D24 (2016) SIOP 2016 Scientific Programme+Index
001D98 (2016) Anais Gardette [France] ; Sébastien Ottaviani [France] ; Jérémie Sellam [France] ; Francis Berenbaum [France] ; Frédéric Lioté [France] ; Bruno Fautrel [France] ; Elisabeth Palazzo [France] ; Alain Meyer [France] ; Jean Sibilia [France] ; Philippe Dieudé [France]Body mass index and response to abatacept in rheumatoid arthritis
001F23 (2015) Yves-Marie Pers [France] ; Marie Godfrin-Valnet ; Joseph Lambert ; Clémentine Fortunet ; Elodie Constant ; Thibault Mura ; Béatrice Pallot-Prades ; Christian Jorgensen ; Jean-Francis Maillefert ; Hubert Marotte ; Daniel Wendling ; Philippe GaudinResponse to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient.
002053 (2015) Raphaèle Seror [France] ; Simon J. Bowman [Royaume-Uni] ; Pilar Brito-Zeron [Espagne] ; Elke Theander [Suède] ; Hendrika Bootsma [Pays-Bas] ; Athanasios Tzioufas [Grèce] ; Jacques-Eric Gottenberg [France] ; Manel Ramos-Casals [Espagne] ; Thomas Dörner [Allemagne] ; Philippe Ravaud [France] ; Claudio Vitali [Italie] ; Xavier Mariette [France]EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
002301 (2014) Hitomi Kobayashi ; Yasuyuki Kobayashi [Oman] ; Jon T. Giles ; Kihei Yoneyama ; Yasuo Nakajima ; Masami TakeiTocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging.
002609 (2014) Abstracts and Index of Authors
002946 (2013) A. Meyer [France] ; A. Theulin ; E. Chatelus ; C. Sordet ; R.-M. Javier ; B. Geny [France] ; J.-E. Gottenberg ; J. SibiliaTHU0412 Reactive hyperemia index (RHI) is associated with macrovascular disease and lung disease in systemic sclerosis
002A49 (2013) L. Del Olmo ; P. Aguado ; J. Coya [Espagne] ; L. Lojo ; L. Nu O ; S. Gil ; E. Martín Mola ; A. BalsaTHU0064 Comparison of estimated fracture risk using the FRAX index calculated with and without bone densitometry in patients with early arthritis
002B21 (2013) I. Castrejon [États-Unis] ; Y. Yazici [États-Unis] ; T. Pincus [États-Unis]SAT0460 Patient self-report joint count, rheumatoid arthritis disease activity index (RADAI), on a multidimensional health assessment questionnaire (MDHAQ) is informative in patients with rheumatic diseases other than rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "index" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "index" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    index
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021